TY - JOUR AU - Blumberg, H. M. AU - Burman, W. J. AU - Chaisson, R. E. AU - Daley, C. L. AU - Etkind, S. C. AU - Friedman, L. N. PY - 2003 DA - 2003// TI - American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis JO - Am J Respir Crit Care Med VL - 167 UR - https://doi.org/10.1164/rccm.167.4.603 DO - 10.1164/rccm.167.4.603 ID - Blumberg2003 ER - TY - JOUR AU - Sharifzadeh, M. AU - Rasoulinejad, M. AU - Valipour, F. AU - Nouraie, M. AU - Vaziri, S. PY - 2005 DA - 2005// TI - Evaluation of patient-related factors associated with causality, preventability, predictability and severity of hepatotoxicity during antituberculosis [correction of antituberclosis] treatment JO - Pharmacol Res VL - 51 UR - https://doi.org/10.1016/j.phrs.2004.10.009 DO - 10.1016/j.phrs.2004.10.009 ID - Sharifzadeh2005 ER - TY - JOUR AU - Sharma, S. K. AU - Balamurugan, A. AU - Saha, P. K. AU - Pandey, R. M. AU - Mehra, N. K. PY - 2002 DA - 2002// TI - Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment JO - Am J Respir Crit Care Med VL - 166 UR - https://doi.org/10.1164/rccm.2108091 DO - 10.1164/rccm.2108091 ID - Sharma2002 ER - TY - JOUR AU - Hest, R. AU - Baars, H. AU - Kik, S. AU - Gerven, P. AU - Trompenaars, M. C. AU - Kalisvaart, N. PY - 2004 DA - 2004// TI - Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/422645 DO - 10.1086/422645 ID - Hest2004 ER - TY - JOUR AU - Tost, J. R. AU - Vidal, R. AU - Cayla, J. AU - Diaz-Cabanela, D. AU - Jimenez, A. AU - Broquetas, J. M. PY - 2005 DA - 2005// TI - Severe hepatotoxicity due to anti-tuberculosis drugs in Spain JO - Int J Tuberc Lung Dis VL - 9 ID - Tost2005 ER - TY - JOUR AU - Singanayagam, A. AU - Sridhar, S. AU - Dhariwal, J. AU - Abdel-Aziz, D. AU - Munro, K. AU - Connell, D. W. PY - 2012 DA - 2012// TI - A comparison between two strategies for monitoring hepatic function during antituberculous therapy JO - Am J Respir Crit Care Med VL - 185 UR - https://doi.org/10.1164/rccm.201105-0850OC DO - 10.1164/rccm.201105-0850OC ID - Singanayagam2012 ER - TY - JOUR AU - Saukkonen, J. J. AU - Cohn, D. L. AU - Jasmer, R. M. AU - Schenker, S. AU - Jereb, J. A. AU - Nolan, C. M. PY - 2006 DA - 2006// TI - An official ATS statement: hepatotoxicity of antituberculosis therapy JO - Am J Respir Crit Care Med VL - 174 UR - https://doi.org/10.1164/rccm.200510-1666ST DO - 10.1164/rccm.200510-1666ST ID - Saukkonen2006 ER - TY - JOUR AU - Dossing, M. AU - Wilcke, J. T. AU - Askgaard, D. S. AU - Nybo, B. PY - 1996 DA - 1996// TI - Liver injury during antituberculosis treatment: an 11-year study JO - Tuber Lung Dis VL - 77 UR - https://doi.org/10.1016/S0962-8479(96)90098-2 DO - 10.1016/S0962-8479(96)90098-2 ID - Dossing1996 ER - TY - JOUR AU - Pande, J. N. AU - Singh, S. P. AU - Khilnani, G. C. AU - Khilnani, S. AU - Tandon, R. K. PY - 1996 DA - 1996// TI - Risk factors for hepatotoxicity from antituberculosis drugs: a case–control study JO - Thorax VL - 51 UR - https://doi.org/10.1136/thx.51.2.132 DO - 10.1136/thx.51.2.132 ID - Pande1996 ER - TY - JOUR AU - Fernandez-Villar, A. AU - Sopena, B. AU - Fernandez-Villar, J. AU - Vazquez-Gallardo, R. AU - Ulloa, F. AU - Leiro, V. PY - 2004 DA - 2004// TI - The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity JO - Int J Tuberc Lung Dis VL - 8 ID - Fernandez-Villar2004 ER - TY - JOUR AU - Wong, W. M. AU - Wu, P. C. AU - Yuen, M. F. AU - Cheng, C. C. AU - Yew, W. W. AU - Wong, P. C. PY - 2000 DA - 2000// TI - Antituberculosis Drug-Related Liver Dysfunction in Chronic Hepatitis B Infection JO - Hepatology VL - 31 UR - https://doi.org/10.1002/hep.510310129 DO - 10.1002/hep.510310129 ID - Wong2000 ER - TY - JOUR AU - Lomtadze, N. AU - Kupreishvili, L. AU - Salakaia, A. AU - Vashakidze, S. AU - Sharvadze, L. AU - Kempker, R. R. PY - 2013 DA - 2013// TI - Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0083892 DO - 10.1371/journal.pone.0083892 ID - Lomtadze2013 ER - TY - JOUR AU - Ungo, J. R. AU - Jones, D. AU - Ashkin, D. AU - Hollender, E. S. AU - Bernstein, D. AU - Albanese, A. P. PY - 1998 DA - 1998// TI - Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus JO - Am J Respir Crit Care Med VL - 157 UR - https://doi.org/10.1164/ajrccm.157.6.9711039 DO - 10.1164/ajrccm.157.6.9711039 ID - Ungo1998 ER - TY - JOUR AU - Devarbhavi, H. AU - Singh, R. AU - Patil, M. AU - Sheth, K. AU - Adarsh, C. K. AU - Balaraju, G. PY - 2013 DA - 2013// TI - Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury JO - J Gastroenterol Hepatol VL - 28 UR - https://doi.org/10.1111/j.1440-1746.2012.07279.x DO - 10.1111/j.1440-1746.2012.07279.x ID - Devarbhavi2013 ER - TY - JOUR AU - Fernandez-Villar, A. AU - Sopena, B. AU - Garcia, J. AU - Gimena, B. AU - Ulloa, F. AU - Botana, M. PY - 2007 DA - 2007// TI - Hepatitis C virus RNA in serum as a risk factor for isoniazid hepatotoxicity JO - Infection VL - 35 UR - https://doi.org/10.1007/s15010-007-6125-9 DO - 10.1007/s15010-007-6125-9 ID - Fernandez-Villar2007 ER - TY - JOUR AU - Liu, Y. M. AU - Cheng, Y. J. AU - Li, Y. L. AU - Liu, C. E. AU - Hsu, W. H. PY - 2014 DA - 2014// TI - Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis JO - Lung VL - 192 UR - https://doi.org/10.1007/s00408-013-9535-8 DO - 10.1007/s00408-013-9535-8 ID - Liu2014 ER - TY - JOUR AU - Lee, B. -. H. AU - Koh, W. -. J. AU - Choi, M. -. S. AU - Suh, G. -. Y. AU - Chung, M. -. P. AU - Kim, H. -. j. PY - 2005 DA - 2005// TI - Inactive HBsAg carrier state and hepatotoxicity during antiTB chemotherapy JO - Chest VL - 127 ID - Lee2005 ER - TY - JOUR AU - Kwon, Y. S. AU - Koh, W. J. AU - Suh, G. Y. AU - Chung, M. P. AU - Kim, H. AU - Kwon, O. J. PY - 2007 DA - 2007// TI - Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy JO - Chest VL - 131 UR - https://doi.org/10.1378/chest.06-2042 DO - 10.1378/chest.06-2042 ID - Kwon2007 ER - TY - JOUR AU - S-J, H. W. A. N. G. AU - J-C, W. U. AU - C-N, L. E. E. AU - F-S, Y. E. N. AU - C-L, L. U. AU - T-P, L. I. N. PY - 1997 DA - 1997// TI - A prospective clinical study of isoniazid-rifampicin-pyrazinamideinduced liver injury in an area endemic for hepatitis B JO - J Gastroenterol Hepatol VL - 12 UR - https://doi.org/10.1111/j.1440-1746.1997.tb00353.x DO - 10.1111/j.1440-1746.1997.tb00353.x ID - S-J1997 ER - TY - JOUR AU - Castro, L. AU - Do Brasil, P. E. AU - Monteiro, T. P. AU - Rolla, V. C. PY - 2010 DA - 2010// TI - Can hepatitis B virus infection predict tuberculosis treatment liver toxicity? Development of a preliminary prediction rule JO - Int J Tuberc Lung Dis VL - 14 ID - Castro2010 ER - TY - CHAP AU - Un-yeoung, G. AU - Hyun-jin, S. AU - Yeon-kyeng, L. AU - Hyosoon, Y. AU - Yoon-sung, P. AU - Hae-young, K. PY - 2012 DA - 2012// TI - Annual report on the notified tuberculosis in korea BT - Korea Centers for Disease Control & Prevention: YANG Byung-guk ID - Un-yeoung2012 ER - TY - JOUR AU - Park, N. H. AU - Chung, Y. H. AU - Lee, H. S. PY - 2010 DA - 2010// TI - Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period JO - Intervirology VL - 53 UR - https://doi.org/10.1159/000252780 DO - 10.1159/000252780 ID - Park2010 ER - TY - JOUR PY - 2014 DA - 2014// TI - KASL clinical practice guidelines: Management of Hepatitis C JO - Clin Mol Hepatol VL - 20 UR - https://doi.org/10.3350/cmh.2014.20.2.89 DO - 10.3350/cmh.2014.20.2.89 ID - ref23 ER - TY - JOUR AU - Wang, C. W. AU - Lin, H. Y. AU - Shin, S. J. AU - Yu, M. L. AU - Lin, Z. Y. AU - Dai, C. Y. PY - 2011 DA - 2011// TI - The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population JO - Liver Int VL - 31 UR - https://doi.org/10.1111/j.1478-3231.2011.02526.x DO - 10.1111/j.1478-3231.2011.02526.x ID - Wang2011 ER - TY - JOUR AU - Tarantino, G. AU - Saldalamacchia, G. AU - Conca, P. AU - Arena, A. PY - 2007 DA - 2007// TI - Non-alcoholic fatty liver disease: further expression of the metabolic syndrome JO - J Gastroenterol Hepatol VL - 22 UR - https://doi.org/10.1111/j.1440-1746.2007.04824.x DO - 10.1111/j.1440-1746.2007.04824.x ID - Tarantino2007 ER - TY - STD TI - Moon H, Lee J. Korean Guidelines for Tuberculosis. Korea: Joint Committee for the Development of Korean Guidelines for Tuberculosis; 2011. ID - ref26 ER - TY - STD TI - WHO: Treatment of tuberculosis guidelines, 4th ed. Geneva, World Health Organization, 2010 (WHO/HTM/STB/2009.420). Available: http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf. UR - http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf ID - ref27 ER - TY - JOUR AU - Dhiman, R. K. AU - Saraswat, V. A. AU - Rajekar, H. AU - Reddy, C. AU - Chawla, Y. K. PY - 2012 DA - 2012// TI - A Guide to the Management of Tuberculosis in Patients with Chronic Liver Disease JO - J Clin Exp Hepatol VL - 2 UR - https://doi.org/10.1016/j.jceh.2012.07.007 DO - 10.1016/j.jceh.2012.07.007 ID - Dhiman2012 ER - TY - JOUR AU - Wedemeyer, I. AU - Bechmann, L. P. AU - Odenthal, M. AU - Jochum, C. AU - Marquitan, G. AU - Drebber, U. PY - 2009 DA - 2009// TI - Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C JO - J Hepatol VL - 50 UR - https://doi.org/10.1016/j.jhep.2008.08.023 DO - 10.1016/j.jhep.2008.08.023 ID - Wedemeyer2009 ER - TY - JOUR AU - Schenker, S. AU - Martin, R. R. AU - Hoyumpa, A. M. PY - 1999 DA - 1999// TI - Antecedent liver disease and drug toxicity JO - J Hepatol VL - 31 UR - https://doi.org/10.1016/S0168-8278(99)80325-0 DO - 10.1016/S0168-8278(99)80325-0 ID - Schenker1999 ER - TY - JOUR AU - Tostmann, A. AU - Boeree, M. J. AU - Aarnoutse, R. E. AU - Lange, W. C. AU - Ven, A. J. AU - Dekhuijzen, R. PY - 2008 DA - 2008// TI - Antituberculosis drug-induced hepatotoxicity: concise up-to-date review JO - J Gastroenterol Hepatol VL - 23 UR - https://doi.org/10.1111/j.1440-1746.2007.05207.x DO - 10.1111/j.1440-1746.2007.05207.x ID - Tostmann2008 ER - TY - JOUR AU - Sun, H. -. Y. AU - Chen, I. -. L. AU - Gau, C. -. S. AU - Chang, S. -. C. AU - Luh, K. -. T. PY - 2009 DA - 2009// TI - A Prospective Study of Hepatitis During Antituberculous Treatment in Taiwanese Patients and a Review of the Literature JO - J Formos Med Assoc VL - 108 UR - https://doi.org/10.1016/S0929-6646(09)60040-1 DO - 10.1016/S0929-6646(09)60040-1 ID - Sun2009 ER -